User profiles for Andreas Voss

Andreas Voss

- Verified email at umcg.nl - Cited by 28680

Andreas Voss

- Verified email at fh-jena.de - Cited by 12823

Andreas Voss

- Verified email at psychologie.uni-heidelberg.de - Cited by 8223

[HTML][HTML] Preventing Surgical-Site Infections in Nasal Carriers of Staphylococcus aureus

…, A Troelstra, ATA Box, A Voss… - … England Journal of …, 2010 - Mass Medical Soc
Background Nasal carriers of Staphylococcus aureus are at increased risk for health care–associated
infections with this organism. Decolonization of nasal and extranasal sites on …

No time for handwashing!? Handwashing versus alcoholic rub can we afford 100% compliance?

A Voss, AF Widmer - Infection Control & Hospital Epidemiology, 1997 - cambridge.org
Handwashing is the most important and least expensive measure to prevent transmission of
nosocomial infections. However, compliance rarely exceeds 40% under study conditions. …

Interpreting the parameters of the diffusion model: An empirical validation

A Voss, K Rothermund, J Voss - Memory & cognition, 2004 - Springer
The diffusion model (Ratcliff, 1978) allows for the statistical separation of different components
of a speeded binary decision process (decision threshold, bias, information uptake, and …

[HTML][HTML] Methicillin-resistant Staphylococcus aureus in pig farming

A Voss, F Loeffen, J Bakker, C Klaassen… - Emerging infectious …, 2005 - ncbi.nlm.nih.gov
We conducted a study among a group of 26 regional pig farmers to determine the methicillin-resistant
Staphylococcus aureus prevalence rate and found it was> 760 times greater than …

Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers

HFL Wertheim, MC Vos, A Ott, A van Belkum, A Voss… - The Lancet, 2004 - thelancet.com
Staphylococcus aureus is the second most frequent cause of nosocomial blood infections.
We screened 14 008 non-bacteraemic, non-surgical patients for S aureus nasal carriage at …

Methods derived from nonlinear dynamics for analysing heart rate variability

A Voss, S Schulz, R Schroeder… - … Transactions of the …, 2009 - royalsocietypublishing.org
Methods from nonlinear dynamics (NLD) have shown new insights into heart rate (HR) variability
changes under various physiological and pathological conditions, providing additional …

[HTML][HTML] Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans

…, D Beaujean, A Voss… - Emerging infectious …, 2007 - ncbi.nlm.nih.gov
In 2003 in the Netherlands, a new methicillin-resistant Staphylococcus aureus (MRSA)
strain emerged that could not be typed with Sma1 pulsed-field gel electrophoresis (NT-MRSA). …

Short-term heart rate variability—influence of gender and age in healthy subjects

A Voss, R Schroeder, A Heitmann, A Peters, S Perz - PloS one, 2015 - journals.plos.org
In the recent years, short-term heart rate variability (HRV) describing complex variations of
beat-to-beat interval series that are mainly controlled by the autonomic nervous system (ANS) …

Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum

…, H Goossens, A Holmes, V Jarlier, A Voss… - … resistance and infection …, 2013 - Springer
Antimicrobial resistance (AMR) is now a global threat. Its emergence rests on antimicrobial
overuse in humans and food-producing animals; globalization and suboptimal infection …

Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis

…, J Karbwang, C Fischer, A Voss… - … England Journal of …, 1999 - Mass Medical Soc
Background There is no effective orally administered medication for any leishmania infection.
We investigated miltefosine, which can be taken orally, for the treatment of Indian visceral …